Filing Flows › Bio Key International (BKYI) › Q2 2026
Bio Key International (BKYI) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 13, 2026
Bio Key International (BKYI) reported revenue of $1.9M for the second quarter 2026 (Q2 2026), +13% from a year earlier and -11% from the quarter before. Operating margin was -27.6%, net loss $577K (30.0% of revenue).
Bio Key International, Q2 2026: revenue $1.9M (+13% year over year), operating margin -27.6%, net loss $577K, operating cash flow −$846K. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.9M | -11% | +13% |
| Operating profit | −$529K | — | — |
| Net earnings | −$577K | — | — |
| Operating cash flow | −$846K | — | — |
What changed
Revenue was $1.9M in Q2 2026, up 13% year over year and down 11% from the previous quarter. License was the largest line at 64% of revenue. License added $423K year over year (up 53%), 190% of the total change. Service declined 28%.
Gross margin was 87.2%, up 14.5 points from Q2 2025. Operating costs exceeded revenue by $529K, an operating margin of -27.6%. Operating expenses fell 5% while revenue rose 13%. The quarter ended with a net loss of $577K, wider than the previous quarter's $205K loss.
Operating cash flow was −$846K. Non-cash charges added back $74K of depreciation and amortization and $43K of share-based compensation. Working capital and other items used $386K.
Questions
What was Bio Key International's revenue in the second quarter 2026?
Bio Key International (BKYI) reported revenue of $1.9M for the second quarter 2026 (Q2 2026), +13% from a year earlier and -11% from the quarter before.
Was Bio Key International profitable in the second quarter 2026?
Operating loss was $529K (-27.6% of revenue) and net loss $577K.